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Introduction
In 2015, approximately 214 million cases of malaria and an estimated 438,000 deaths were reported worldwide, with an estimated fall in incidence of 37% between 2000 to 2015 [1] .
Africa remains the most affected continent, with approximately 90% of all malaria cases and
92% of malaria deaths (WHO).
The UK has the second highest number of imported cases in Europe, following France [2] . In the last five years half of all cases reported in the UK occurred in London. This is likely to be a reflection of the ethnic diversity of the London population and also their travelling habits.
In 2001, it was estimated that 8% of the total UK population were born abroad. In 2014 the figure was over 14% and in London the estimate is above 36% [3] .
More than half of malaria cases are individuals travelling to visit friends and relatives in their country of origin. Cases occur in visitors and new entrants to the UK from abroad, as well as individuals travelling abroad from the UK for holiday or business. Changes in travel patterns and migration, as well as changes in the global epidemiology of malaria are likely to have an impact on the number of imported cases. However, the risk of malaria can be reduced by taking bite prevention measures, such as the use of bed nets and mosquito repellents, as well as taking appropriate chemoprophylaxis [4] .
Under the Health Protection (Notification) Regulations 2010 malaria is a notifiable disease [5] and all positive specimens should be sent to the Public Health England (PHE) Malaria
Reference Laboratory (MRL) for confirmation. Each specimen should be accompanied by a surveillance questionnaire that collects basic demographics, travel history and whether chemoprophylaxis was taken or not [6] . London may mirror the situation in other global cities in non-endemic countries and could provide valuable information for malaria prevention.
Methods
Malaria reference laboratory data
Data on malaria cases in the UK is collected by the PHE MRL housed at the London School of
Hygiene & Tropical Medicine and managed by the PHE Travel and Migrant Health Section. This is the most complete dataset on malaria in the UK [7] . We conducted a cross-sectional study of the cases confirmed by the PHE MRL between 2000 and 2014 presumed to be resident within London.
From 2013 onwards, missing data was supplemented where available, using HPZone (HPZone TM Infact Shipley, Yorkshire) which is an online case management tool that it is used by the health protection teams in England. Individuals with malaria that were on HPZone but not on the MRL data were added into a final dataset. Cases were classified according to reason for travel when provided. When missing, country of usual residence was used instead to classify cases into "travelled abroad from the UK" or "foreign visitors". Where country of travel was missing, we used world region of travel.
Hospital episode statistics
Information on hospital admissions, length of stay by main speciality and age was obtained from the Hospital Episode Statistics © (HES). This is a secured data warehouse managed by the Health and Social Care Information Centre that contains details of all National Health Service (NHS) admissions in England [8] . This included all the finished admissions episodes in residents in London admitted to hospital between 2000 and 2014 that mentioned malaria in any of the diagnosis fields. Therefore, admissions do not represent the number of patients, as a person may have more than one admission within the study period.
Descriptive analysis
We calculated the incidence per year using midyear population estimates for 2014 from the Office for National Statistics (ONS) [9] . We mapped the rates for 2014 by local authority using ArcGISM A N U S C R I P T A C C E P T E D 
Cost analysis of hospital admissions for the financial years 2009/2010 to 2014/2015
The NHS national tariff payment system [14] for and applying it to each admission. In London, the majority of malaria cases were due to P. falciparum (82%, 12,713/15,357), 
Results
Descriptive analysis of all malaria cases in London between
Descriptive analysis of cases of malaria that travelled abroad, London 2000 to 2014
Out of the total number of cases reported in London between 2000 and 2014, 50% Although it appears that the number of individuals taking chemoprophylaxis declined there is significant missing data and information regarding the appropriateness of chemoprophylaxis taken and whether individuals adhered to the regimen was unavailable.
Descriptive analysis of deaths due to malaria reported in London between 2000 and 2014
Since 2000, 44 deaths due to malaria were reported in London, with a case fatality rate 
Descriptive analysis of admissions between 2000 and 2014 and economic costing of admissions reported by HES for the financial years 2009/2010 to 2014/2015
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A total of 13,916 malaria hospital admissions were reported by HES between 2000 and 2014 (Table 3) . Overall, the total number of admissions fell between 2000 and 2014, and the average length of stay decreased (Table 3 ). The majority of admissions did not have a speciality listed. Admissions predominantly occurred in adults aged between 15 and 60 years, and the shift in age distribution is observed between 2000 and 2014, with an increase in admissions in older age groups (Table 3) .
Between 2009/2010 and 2014/2015 the number of malaria admissions was over four and a half thousand. The average length of stay was two days. Overall, the crude estimate of cost was over £6 million and on average it was just over a £1 million per study year (Table 4) 
Discussion
The results of this study are largely in accordance with previous findings for London [15] and with the national review of malaria [16] . This study showed that the rates of malaria in
London have declined between 2000 and 2014. The reasons for the decline are unclear.
Previous studies in the UK suggested a decline in malaria transmission in West Africa as a possible explanation [17] . In Amsterdam the decline in number of cases observed up until 2002 were attributed to a decrease in nonimmune patients [18] . However, this was followed by an increase in the Netherlands most notably since 2013 and mostly due to immigration of asylum seekers from the horn of Africa and among VFRs [19] . An increasing trend in malaria cases between 1973 and 2013 was also seen in the US, a country with a similar epidemiology to the UK where malaria affected mostly VFRs and travellers to Africa, specifically Nigeria [20] . Increases in the US were mostly attributed to inadequate use of appropriate prevention measures by travellers [20] .
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The epidemiological description of cases in London suggests that males were more likely to have malaria, with cases predominantly occurring in adults aged between 15 and 60 years, possibly reflecting UK travel patterns. The highest rates of malaria were among individuals The number of cases peaked in July-September each year, in line with the UK school summer holiday when individuals are most likely to travel abroad. This also coincides with the high-transmission rainy season in West Africa. The majority of malaria cases were due to P. falciparum, and this reflects the fact that most cases travelled to sub-Saharan Africa.
In recent years there has been a shift in the age distribution of cases, with an increase in older age groups (45-60 years). This was observed in both notifications and inpatient admissions. One possible explanation is that older individuals are less susceptive to M A N U S C R I P T
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13 preventative messages if they have been born in a malaria endemic country and so may underestimate their risk compared with individuals born in the UK. In addition they are at higher risk of mortality. In support of this, the proportion of individuals born in endemic countries increased over the study period, particularly in people over 40 years old. However, completion rates for country of birth were poor (45%). Increases in visits abroad from 2000 to 2015 were observed in people over 65 years of age, but no apparent increases in trends were seen in age groups 45-54 and 55-64 suggesting that these groups are not necessarily travelling more. Further work on the reasons for this shift in age distribution is required to better understand it.
Only 15% of cases travelling abroad from London reported taking chemoprophylaxis.
Furthermore, the proportion of cases that took appropriate chemoprophylaxis for the travel destination is likely to be lower. A study by Smith et al showed that use of chemoprophylaxis varied according to the geographical origin of the individual, with the lowest reported uptake in individuals from Africa and South Asia [21] . In addition, they reported that VFRs were less likely to report taking prophylaxis compared with other travellers. A number of different reasons for not taking chemoprophylaxis have been described, including cost, low perception of personal risk, failure to access the drugs prior to travel, lack of knowledge and scepticism over the efficacy of the drugs. However, other reasons include: feelings of competence amongst VFRs in their ability to self-manage the disease and that of doctors and other health care workers in their country of origin to diagnose and treat malaria appropriately. Also there was a perceived poor confidence in physicians in their country of residence to treat illnesses related to overseas travel, and malaria when returning [22] [23] [24] . Similar findings were shown in a study exploring adherence M A N U S C R I P T
14 to malaria prevention guidelines by US residents of Nigerian origin [25] . Some studies looking into malaria perceptions and practices in VFRs suggest that the decisions about malaria prevention in this group are complex and that preventive measures based on a knowledge deficit approach e.g. raising awareness may not be sufficient to have an impact in behaviour [26] . One option is to provide subsidised malaria chemoprophylaxis to increase uptake, and the results of a modelling study suggests that this is a cost-effective policy for reducing imported malaria cases [27] . Conversely, a study undertaken in the UK evaluating this strategy failed to demonstrate an impact on malaria prevention. It also appears that the use of chemoprophylaxis has declined in this group but there was a high proportion of missing information on chemoprophylaxis so this should be interpreted with caution. The decline in the use of chemoprophylaxis could be further explored by looking at prescription data, as done by Guedes et al 2010 in Finland [29] . However, this could be challenging as a lot of them are likely to be private prescriptions. In addition, no information regarding bite prevention measures was available in this study. This is one of the key public health messages given to travellers and it would be of interest to evaluate this in the future.
The number of deaths due to malaria has remained stable since 2000, with a CFR of 0.3%.
Previous studies have shown that the mortality risk is higher in elderly individuals and tourists [30, 31] . However, due to the small number of deaths in this study, no trends could be observed.
The total number of admissions is lower compared with the total number of cases in the MRL dataset, as it only includes inpatients. Some hospitals do not routinely admit nonsevere malaria. However this dataset may overestimate the number of inpatients as it does not differentiate between readmissions of the same patient.
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The crude cost of malaria in London has declined as cases have reduced however it still represents just over a million pounds per year to the NHS in inpatient costs. However, these costs do not take into account other healthcare costs including outpatient, and nonhealthcare community costs and costs to the individual and family so the actual cost may be more than this. As malaria is preventable, this is a cost that could be reduced. This highlights the importance of preventative messages and strategies that can specifically target the most affected groups in London.
Limitations
Firstly, in this study changes in travel behaviour of London residents have not been taken into account. Since 2000 there has been a 5.3% annual increase in individuals travelling to visit friends and relatives, resulting in an increasing potential for exposure [32] . Secondly, the number of cases of malaria reported here are likely to be an under-estimate of the true number of cases. A previous capture-recapture study estimated that only 62% of all cases in London were captured by the MRL, although completion rates are highest for p. falciparum malaria [33] . Thirdly, the completeness of the data is likely to have been improved from 2013 onwards [34] . However, it remains poor for some of the fields for the previous years.
In addition other relevant information such as whether individuals followed bite prevention guidelines was not available.
When interpreting the cost estimates, there are a number of factors than need to be considered. Firstly, the costs were estimated using national prices, and therefore the costs for London may differ compare to the rest of the country. In addition, this is just an estimate of the cost, and true cost may vary, for example different tariffs other than the national tariff may have been used. Furthermore, we considered all patients to be non-elective, and M A N U S C R I P T
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16 this will over-estimate the cost for elective patients (although the number of elective patients for malaria is likely to be low). The A&E tariff applied to the admissions is likely to underestimate the cost for some of the cases as we only applied Category 1. Some admissions were likely to require a higher level of care while in A&E. Additionally, the cost of different specialties was not considered, for example intensive care is likely to be more costly, and therefore this may underestimate the overall cost. However, the number of patients in these specialities was low. Finally, HES data only includes NHS admissions so patients treated privately or cases that did not required admission to hospital are not included.
Despite these limitations the results are based on a large dataset over a 15 year period, which allows the possibility to observe trends, and changes over time.
Conclusion
Overall, the number of cases of malaria in London has declined since 2000. This is in line with a 37% decline in the global incidence of malaria in the same time period. The global decline is likely to be due to advances in malaria control in endemic countries [1] . Better control measures in endemic countries may have had an impact on the number of cases occurring in London [1] . This might be more important for VFRs who might benefit from improvements in control measures targeting the local population in endemic countries.
However, it is unclear how this may actually occur and also it would not explain the increases seen in other places such as the US and the Netherlands or the fact that the overall decline of cases in VFRs in London has remain unchanged since 2000. VFRs, especially those travelling to Nigeria, remain the most affected with a significant decline in M A N U S C R I P T
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In the majority of circumstances, malaria remains a preventable disease. Efforts should focus on ensuring that appropriate pre-travel advice is provided, including bite prevention, 
